ARTICLE | Clinical News
Allob: Phase IIa started
September 29, 2014 7:00 AM UTC
Bone Therapeutics began an open-label, Belgian Phase IIa trial to evaluate a single dose of Allob mixed with bioceramic granules in about 16 patients with symptomatic degenerative lumbar disc disease ...